(2S,3S)-2-(2-Aminoacetamido)-3-methylpentanoic acid, 95.0%, 250mg

4-(1H-Tetrazol-5-yl)benzoic Acid>98.0%(HPLC)(T)1g

Sodium hydroxide solution 0.5%, 0.5%, extra pure, 25 l, plastic packaging.

4-BROMO-2-IODOBENZYL BROMIDE, 95.0%, 100mg

2-hydrazino-6-(methoxymethyl)pyrimidin-4(3H)-one, 500mg

4,4-Dioxo-1,4-oxathiane>98.0%(GC)5g

6-Methoxybenzo[b]thiophene-2-carboxylic acid, 95.0%, 5g

4-Methyl-1H-benzimidazole-2-carboxylic acid, 97.0%, 250mg

3,6-Dichloropyridazin-4-ol, 95.0%, 10g

2-Bromo-benzenebutanol, 97%, 100mg

((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate, 97%, 1g

4,7,10,13,16,19-Hexaoxaheneicosanoic acid, 21-amino-, 1,1-dimethylethyl ester, 97%, 100mg

3-((2S,5S)-5-Methyl-3,6-dioxopiperazin-2-yl)propanoic acid, 95.0%, 250mg